Defense Stock Domin...
Health Care: Health Services
Ironwood Pharmaceuticals Inc. (IRWD: NASDAQ)
$12.52 -0.39 | -3.02%
05/23/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -72.62M | -64.85M | -51.86M | -73.31M |
| Operating Gains/Losses | 20.00K | 7.00K | 474.00K | 80.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -835.00K | 2.24M | 2.32M | -465.00K |
| (Increase) Decrease in Inventories | -6.70M | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 2.83M | -2.35M | -463.00K |
| (Decrease) Increase In Payables | 24.24M | 5.09M | 2.74M | 1.57M |
| (Decrease) Increase In Other Current Liabilities | -1.35M | -1.13M | -4.26M | 2.75M |
| (Increase) Decrease In Other Working Capital | -37.32M | -45.81M | -17.08M | 55.39M |
| Other Non-Cash Items | 17.57M | 13.97M | 4.56M | 5.77M |
| Net Cash From Continuing Operations | -69.63M | -75.24M | -61.93M | -4.00M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | -5.97M | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -69.63M | -75.24M | -67.90M | -4.00M |
| Sale of Property, Plant & Equipment | 9.00K | 4.00K | 1.00K | 21.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 140.76M | 222.25M | 236.48M | 48.46M |
| Purchases of Property, Plant & Equipment | -13.98M | -9.68M | -17.22M | -4.04M |
| Acquisitions | 0.00 | 0.00 | 9.50M | 0.00 |
| Purchases of Short-Term Investments | -96.71M | -97.51M | -441.80M | -26.67M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 30.08M | 115.06M | -213.04M | 17.76M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 2.64M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 89.25M | 3.39M | 205.19M | 40.52M |
| Repayment of Long-Term Debt | -275.00K | -260.00K | -1.96M | -1.50M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 88.97M | 3.13M | 202.96M | 41.66M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 49.42M | 42.96M | -77.98M | 55.42M |
Portfolios with IRWD
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Pharma Stocks With Upside
- ProBridger Management
- ContributorRocket Stocks for the Week ...
- ContributorBarron's Insider Purchases ...
Latest IRWD Headlines from TheStreet
- Ironwood Pharmaceuticals Is Now Oversold (IRWD) 05.22.13 | 04:05 pm
- Ironwood Pharmaceuticals Enters Oversold Territory (IRWD) 05.01.13 | 12:05 pm
- 3 Stocks Underperforming Today In The Health Services Industry 04.25.13 | 01:04 pm
- Ironwood's Constipation Drug Sales Disappoint 04.23.13 | 08:04 am
- Top Insider Trades: ATVI, SCS, KSS, IRWD 04.03.13 | 07:04 am
- Analysts' Actions: FCX IRWD RIG SCHW ULTA 03.15.13 | 08:03 am
- Cramer's 'Mad Money' Recap: The Bullish Facts 01.17.13 | 08:01 pm
- Ironwood Pharmaceuticals Inc. Stock Downgraded (IRWD) 01.17.13 | 04:01 am
- Analysts' Actions: AAPL DELL IRWD K SEE FB 01.16.13 | 08:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.14.13 | 12:01 pm
Press Releases for IRWD
- Edward Owens, Ironwood Board Of Directors (Photo: Business Wire) - Business Wire 03.04.13 | 08:03 am
- Ironwood Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 04:02 pm
- Mark Currie, Ph.D., Senior Vice President, CSO, And President Of R&D Of Ironwood Pharmaceuticals, Inc. (Photo: Business Wire) - Business Wire 02.11.13 | 09:02 am
- Ironwood Pharmaceuticals Provides Fourth Quarter 2012 Investor Update - Business Wire 01.15.13 | 07:01 am
- Ironwood Pharmaceuticals To Host Fourth Quarter 2012 Investor Update Call - Business Wire 01.10.13 | 04:01 pm
- Ironwood Completes $175 Million Debt Offering - Business Wire 01.04.13 | 10:01 am
- Ironwood Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- FACT SHEET -- Chronic Idiopathic Constipation - Business Wire 12.17.12 | 08:12 am
- Protagonist And Ironwood Expand Peptide Drug Discovery Collaboration - Business Wire 12.06.12 | 08:12 am
- Constella® (linaclotide) Approved In Europe For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)in Adults - PR Newswire 11.28.12 | 10:11 am
Partner Headlines for IRWD
- Pre-Market Most Active for May 22, 2013 : NTAP, PFE, NMR, RDS/A, RDS/B, NOK, SNE, PGTI, IRWD, GILD, VOD, ZNGA - NASDAQ 05.22.13 | 12:05 pm
- EU Approval for Ironwood's Constella - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- Earnings Scorecard: Forest Labs - Analyst Blog - Zacks 10.26.12 | 06:10 pm
- Ironwood and AstraZeneca Announce Linaclotide Collaboration for China - Benzinga 10.23.12 | 09:10 am
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - Zacks 08.31.12 | 05:08 pm
- Hedging Ironwood before ruling - NASDAQ 08.28.12 | 09:08 am
- Ironwood Pharmaceuticals, Earnings Call INSIGHTS: Huge Opportunity in CC, Feeling Good About Commercial Readiness - Wall St. Cheat Sheet 07.18.12 | 11:07 am
- Delay in Forest Drug FDA Action Date - Analyst Blog - Zacks 03.30.12 | 05:03 pm
- Forest-Janssen Sue Generic Players - Analyst Blog - Zacks 03.16.12 | 07:03 pm
